Autism spectrum disorders

Autism spectrum disorders (ASD) are neurodevelopmental conditions characterized by impairments in social interaction, communication, and behavioral patterns. Symptoms may appear at different ages and with varying degrees of severity, affecting learning, behavior, and a child’s quality of life.

While conventional care and support typically include behavioral interventions, psychotherapy, and supportive therapies, contemporary research highlights the potential of regenerative approaches — particularly cell therapy — as a complementary option to support nervous system function and improve quality of life.

Stem cells influence the nervous system not by “replacing damaged cells,” but by activating the child’s own regenerative and regulatory processes.

Immunomodulatory effects
In some children with ASD, increased immune activity and chronic inflammation are observed. Stem cells help “calm” these immune responses by restoring immune balance, which may positively impact brain function and behavioral regulation.

Paracrine signaling (via bioactive molecules)
After administration, stem cells release growth factors and regulatory molecules that stimulate tissue repair, support the formation of neural connections, and enhance the brain’s capacity for adaptation and learning.

Neuroprotective effects
Stem cells create a supportive environment for neurons, protecting them from damage and helping maintain normal neural function.

Together, these mechanisms aim to improve nervous system performance and reduce biological factors that may interfere with a child’s development.

For children with autism spectrum disorders, the following cell types have shown the most promising potential in clinical research:

1. Autologous umbilical cord blood or mesenchymal stromal cells derived from the umbilical cord
These are cells preserved at birth in a biobank. They demonstrate high biological activity and are fully compatible with the child’s body.

2. Umbilical cord blood or MSCs from the umbilical cord or placenta of a sibling
This material may be used if the child’s own stored cells have already been utilized or were not preserved at birth.

3. Donor-derived umbilical cord blood cells or MSCs from the umbilical cord and placenta
These cells have demonstrated safety and potential therapeutic benefits in clinical studies and regenerative medicine programs.

The selection of a specific cell type is determined by the physician following a comprehensive medical evaluation of the child’s condition, taking into account individual indications, the route of cell administration, and therapeutic goals.

t is important to understand that cell therapy is not a “miracle cure” for autism. Its purpose is to support the child’s nervous system through natural biological mechanisms, contributing to improved development, learning capacity, and social adaptation.

When combined with behavioral programs and rehabilitation, the following changes may be observed:

• improved concentration and engagement in learning

• reduced frequency of stereotypical or excessive behavioral responses

• calmer interaction with others

• more stable emotional responses

• improved overall well-being and endurance

The results of cell therapy may vary from child to child and require long-term follow-up and multidisciplinary support.